Universal Bacterium-Vectored COVID-19 Vaccine Expressing Early SARS-CoV-2 Conserved Proteins Cross-Protects Against Late Variants in Hamsters

By afschroeder • June 27, 2025

Jia Q, Bielefeldt-Ohmann H, Masleša-Galić S, Bowen RA, Horwitz MA. Universal Bacterium-Vectored COVID-19 Vaccine Expressing Early SARS-CoV-2 Conserved Proteins Cross-Protects Against Late Variants in Hamsters. Vaccines (Basel). 2025 Jun 12;13(6):633. doi: 10.3390/vaccines13060633. PMID: 40573964.

Tags: covid-19, Delta variant, Infectious Diseases, LVS DeltacapB vector, membrane protein, nucleocapsid protein, Omicron variant, Publications, RdRp, SARS-CoV-2, single-vector platform, vaccine

Enabling Ciprofloxacin Resistance-Guided Therapy for Neisseria gonorrhoeae: Aligning Diagnostics, Regulation, Guidelines, and Reimbursement

Trainor BW, Osborn JL, Klausner JD, Satlin MJ, Buss SN, Scheffer-Wong A, Harris A, Van Der Pol B, Deal C, Nenninger A, Mokany E, Moon[...]

Changes in attitudes toward the HPV vaccine in Kenya

Moucheraud C, Miao J, Ochieng E, Zhang S, Ganda G, Golub G, Hoffman RM, Szilagyi PG, Suen SC. Changes in attitudes toward the HPV vaccine[...]

Risk of Hepatocellular Carcinoma or Hepatic Decompensation Associated With Steatotic Liver Disease in People With and Without HIV

Torgersen J, Newcomb CW, Skanderson M, Kidwai-Khan F, Carbonari DM, Tate JP, Mezzacappa C, Cartwright EJ, Bhattacharya D, Lim JK, Price JC, Taddei TH, Justice[...]